STAAR SURGICAL CO STAA

About STAAR SURGICAL CO (STAA): stock profile, AI score and financials

STAAR SURGICAL CO (STAA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores STAA at 29.7/100 on a composite quality score built from its SEC filings, placing it at rank #2,487 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (17.5) and free cash flow (23.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 13.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), STAAR SURGICAL CO reports quarterly revenue of $93.5M, net income of $8.1M, an operating margin of 10.8%. Top institutional holders of STAA by reported 13-F value include BROADWOOD CAPITAL, BlackRock, Madison Avenue Partners, based on the most recent SEC filings. STAA trades on the Nasdaq exchange and files with the SEC under CIK 718937. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate STAA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for STAAR SURGICAL CO directly from SEC EDGAR.

Financials through the period ended Jul 3, 2026SEC EDGAR: CIK 718937 →